Noncoding RNAs as novel biomarkers in prostate cancer
CGH Rönnau, GW Verhaegh… - BioMed research …, 2014 - Wiley Online Library
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
[PDF][PDF] Noncoding RNAs as Novel Biomarkers in Prostate Cancer
CGH Rönnau, GW Verhaegh, MV Luna-Velez… - 2014 - pdfs.semanticscholar.org
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
[PDF][PDF] Noncoding RNAs as Novel Biomarkers in Prostate Cancer
CG Ronnau, G Verhaegh, MV Luna-Velez… - 2014 - repository.ubn.ru.nl
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
[PDF][PDF] Noncoding RNAs as Novel Biomarkers in Prostate Cancer
CGH Rönnau, GW Verhaegh, MV Luna-Velez… - 2014 - Citeseer
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
[HTML][HTML] Noncoding RNAs as Novel Biomarkers in Prostate Cancer
CGH Rönnau, GW Verhaegh… - BioMed Research …, 2014 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
Noncoding RNAs as Novel Biomarkers in Prostate Cancer.
CGH Rönnau, GW Verhaegh… - BioMed Research …, 2014 - search.ebscohost.com
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
Noncoding RNAs as Novel Biomarkers in Prostate Cancer
CGH Ronnau, GW Verhaegh… - BioMed Research …, 2014 - hero.epa.gov
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
Noncoding RNAs as Novel Biomarkers in Prostate Cancer
CGH Rönnau, GW Verhaegh, MV Luna-Velez… - BioMed Research …, 2014 - cir.nii.ac.jp
抄録< jats: p> Prostate cancer (PCa) is the second most common diagnosed malignant
disease in men worldwide. Although serum PSA test dramatically improved the early …
disease in men worldwide. Although serum PSA test dramatically improved the early …
Noncoding RNAs as Novel Biomarkers in Prostate Cancer
CGH Rönnau, GW Verhaegh… - BioMed Research …, 2014 - search.proquest.com
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
Noncoding RNAs as novel biomarkers in prostate cancer
CGH Ronnau, GW Verhaegh, MV Luna-Velez… - BioMed Research …, 2014 - go.gale.com
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …